Article
Immune Microenvironment and Genetics in Malignant Pleural Mesothelioma
11 Jun 2021
Abstract excerpt
Malignant pleural mesothelioma (MPM) is a rare and aggressive malignancy with limited therapeutic options beyond surgery and cytotoxic chemotherapy. The success of immune checkpoint inhibition has been found to correlate with expression of immune-related genes such as CD274 (PD-L1) in lung and other solid cancers. However, only a small subset of MPM patients respond to checkpoint inhibition, and this response has...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
